Viewing Study NCT05573958


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2025-12-25 @ 10:22 PM
Study NCT ID: NCT05573958
Status: UNKNOWN
Last Update Posted: 2022-10-10
First Post: 2022-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
Sponsor: Sarmad Zahoor
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module